Nanocovax is a Vietnamese COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology JSC. It is a subunit vaccine (SARS‑CoV‑2 recombinant spike protein with aluminum adjuvant).
== Medical uses == The vaccine requires two doses, administered 28 days apart. It is given by intramuscular injection.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).